Topic: Supply Chain
-
Blueprints for Indication-Specific Pricing
-
Understanding the Rewards of Successful Drug Development: Thinking Inside the Box
-
Impact of President’s Budget and Point of Sale Rebate Proposal for Part D: 10 Year Projection
-
List Price, Net Price, and the Rebate Caught in the Middle
-
Spending On Prescription Drugs In The US: Where Does All The Money Go?
-
Copay Assistance: The Epipen Example